GBS Stock - GBS Inc.
Unlock GoAI Insights for GBS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $3.05M | $3.11M | $1.26M | $437,146 | $1.98M |
| Gross Profit | $1.25M | $1.43M | $326,668 | $437,146 | $1.98M |
| Gross Margin | 40.8% | 45.8% | 26.0% | 100.0% | 100.0% |
| Operating Income | $-10,644,607 | $-10,283,174 | $-12,595,233 | $-8,336,876 | $-5,573,482 |
| Net Income | $-10,568,733 | $-10,156,759 | $-10,631,720 | $-8,295,612 | $-7,037,286 |
| Net Margin | -346.2% | -326.4% | -845.9% | -1897.7% | -355.3% |
| EPS | $-2.00 | $-6.10 | $-10.58 | $-0.57 | $-0.52 |
GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. GBS Inc. has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was incorporated in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Visit WebsiteEarnings History & Surprises
GBSEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2023 | Dec 31, 2023 | — | $-2.07 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-1.04 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-4.27 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-5.72 | — | — |
Q4 2022 | Dec 31, 2022 | — | $1.32 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.08 | — | — |
Q3 2022 | Aug 31, 2022 | $-0.18 | $-0.14 | +22.2% | ✓ BEAT |
Q2 2022 | May 10, 2022 | $-0.16 | $-0.09 | +43.8% | ✓ BEAT |
Q1 2022 | Feb 10, 2022 | $-0.16 | $-0.23 | -43.8% | ✗ MISS |
Q4 2021 | Nov 12, 2021 | — | $-0.10 | — | — |
Q3 2021 | Sep 16, 2021 | — | $-0.07 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.27 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.23 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.09 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.04 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.02 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.16 | — | — |
Q3 2019 | Sep 30, 2019 | — | $-0.07 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.28 | — | — |
Q1 2019 | Mar 31, 2019 | — | $-0.14 | — | — |
Latest News
Frequently Asked Questions about GBS
What is GBS's current stock price?
What is the analyst price target for GBS?
What sector is GBS Inc. in?
What is GBS's market cap?
Does GBS pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to GBS for comparison